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1 / Introduction to cell death 
Cell death is the biological process by which cells end carrying out their functions 
and die. Currently, it is widely accepted that cell death is an essential process precisely 
regulated and involved in homeostasis maintenance [1]. However, cell death was initially 
assumed as a damaging process induced by pathological factors. It was not until 1842 that 
Karl Vogt proposed the existence of physiological cell death in developmental processes [2]. 
The concept of programmed cell death appeared for the first time in 1964 when Lockshin 
and Williams described regulated cell death during insect metamorphosis [3]. Afterwards, 
Schweichel and Merker examined by electron microscopy cell death throughout the 
embryonic development of rodents treated with or without embryotoxic substances [4]. This 
study led them to report the existence of three different types of cell death regarding the 
morphology of the dying cells. Type I was related to heterophagy, type II was related to 
autophagy and type III did not include digestion events. In 1990, Clarke did a more detailed 
classification of cell death typologies based on Schweichel and Merker’s work [5]. Clarke’s 
studies allowed the generation of the current classification in which cell death type I, II and 
III are referred to as apoptosis, cell death associated with autophagy and necrosis, 
respectively. The current classification includes both morphological and biochemical 
features that are distinct in each cell death process.     
Apoptosis  
In 1972, Kerr, Wyllie and Currie coined the term apoptosis [6]. Cells undergoing 
apoptosis suffer nuclear condensation and fragmentation, along with extensive hydrolysis 
of nuclear DNA. They become rounded and retract from neighbouring cells. The plasma 
membrane starts blebbing and many of these blebs usually detach from the membrane, 
generating small free vesicles named apoptotic bodies, which contain cytoplasmic and 
nuclear fractions (Fig. 1A). Apoptotic bodies and cells are rapidly recognised and degraded 
by phagocytes, permitting to recycle the cellular contents and avoiding the cytoplasmic 
content leakage. This is thought to be essential to prevent neighbouring cell damage by 
limiting the release of intracellular molecules that are related either with the generation of 
direct cell damage or the activation of unwanted immune responses [7,8].  
	 With regards to the molecular basis, there are different apoptosis activation 
pathways and all of them culminate in activating several members of a family of cysteine 
proteases known as caspases. The extrinsic apoptotic pathway is triggered by the binding 
of extracellular ligands, such as tumour necrosis factor-α (TNFα), to transmembrane death 
receptors. The signaling cascade culminates with the activation of caspase 8, which in turn 
activates effector caspases 3 and 7 [7,8,9]. The intrinsic apoptotic pathway can be initiated 
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by different stressing and damaging stimuli and involves the loss of mitochondrial 
membrane integrity. The intermembrane space protein cytocrome c and the caspase 9 are 
the leading molecules in this pathway [9,10]. 
Cell death associated with autophagy 
As mentioned before, Lockshin and Williams introduced the expression programmed 
cell death more than 40 years ago. Remarkably, this first example of programmed cell death 
had the morphology of cell death associated with autophagy. This type of cell death occurs 
in the absence of chromatin condensation but is accompanied by large-scale autophagic 
vacuolisation of the cytoplasm [7,11] (Fig. 1B). The autophagic vesicles can be 
autophagosomes or autolysosomes. The former are double-membraned vesicles that 
contain cytosol or morpholo-gically intact cytoplasmic organelles. The latter arise from the 
fusion of autophagosomes and lysosomes. They are single membrane vesicles that contain 
degenerating organelles undergoing macroautophagy [11]. Even though there is no doubt 
that cells can manifest extensive autophagy shortly before or during their death, it is 
difficult to assess whether the autophagy is the inherent death cause or not [12].  
Necrosis and Regulated Necrosis 
For a long time, apoptosis was considered the standard programmed cell death 
process. Instead of that, necrosis was mostly considered an accidental cell death process 
that only occurs in pathological circumstances. Nonetheless, it is clear nowadays that 
necrosis can occur in a finely regulated manner during both physiological and pathological 
processes. This paradigm shift was due to the discovery of genetic evidence and chemical 
inhibitors for necrosis [1]. Necrotic cell death is morphologically characterised by cellular 
and organelle swelling, cytoplasmic granulation, plasma membrane rupture and subsequent 
loss of intracellular contents [1,11] (Fig. 1C). These morphological qualities are shared by 
multiple modes of regulated necrotic cell death that have distinct underlaying signalling 
pathways like necroptosis, parthanatos, oxytosis, ferroptosis, ETosis, NETosis, pyronecrosis 
or pyroptosis.  
	 The current work will focus on necroptosis pathway. The term necroptosis was 
originally generated to indicate a specific case of regulated necrosis. Recently, the same 
term has been used as a synonym of regulated necrosis. The Nomenclature Committee on 
Cell Death (NCCD) encourages the use of this last acceptation in scientific publications. 
However, necroptosis can be used in its original meaning provided that this expression is 
explicitly defined at its first appearance and used consistently thereafter [12]. In the current 
work the word necroptosis will be used referring to its specific meaning. 
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 2 / Necroptosis 
Necroptosis is a regulated type of cell death that occurs in cells in which the 
execution of apoptosis is inhibited. Therefore, necroptosis is an alternative mode of cell 
death that can be triggered by pro-apoptotic stimuli, but it is developed in a caspase-
independent manner and shows morphological characteristics resembling necrosis [13]. 
Even though the molecular basis of necroptosis is not fully elucidated, it is known that it is 
executed in a highly regulated manner by a specific set of molecules — receptor-interacting 
protein 1 (RIPK1) and 3 (RIPK3), as well as mixed lineage kinase domain-like protein (MLKL) 
are the most relevant ones. A description of this molecular pathway is provided next.  
Inducing necroptosis 
Necroptosis can be promoted by different stimuli. The best known way to induce 
necroptosis is through death receptors activation, which is also a common way to induce 
apoptosis. Death receptors is a plasma membrane integral protein family which includes 
CD95 (also known as FAS), TNF receptor 1 (TNFR1) and 2 (TNFR2), TNF-related apoptosis-
inducing ligand receptor 1 (TRAILR1) and 2 (TRAILR2), amongst others [14]. Moreover, It has 
been discovered that necroptosis can also be triggered by several members of the pathogen 
recognition receptor (PRR) family. These receptors are expressed in cells of the innate 
immune system and are activated when they bind pathogen-associated molecular patterns 
(PAMPs). PRRs can be both plasma membrane or endosome membrane-associated 
proteins such as Toll-like receptors (TLRs). TLR3 and TLR4, activated by double-stranded 
RNA (dsRNA) and lipopolysaccharide (LPS) respectively, are two of the most studied PRRs 
related to necroptosis. Finally, there are also cytosolic PRRs that might be related to 
necroptosis induction [1, 14].  
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Figure 1. 
A B C
Figure 1. Cell death can happen in three different ways that show distinct morphologies. (A) 
Apoptosis in characterised by cell-rounding, nuclear fragmentation and membrane integrity 
maintenance, (B) cell death associated to autophagy shows cytoplasmic vacuolarization and (C) 
necrosis displays cytoplasmic granulation and membrane integrity loss. 
Making a choice  
Currently, the TNFR1 necroptosis-inducing pathway is the most extensively 
characterised necroptotic pathway. It is strikingly remarkable that cell exposure to TNFR1 
ligand, TNFα, can result in cell survival, apoptosis or necroptosis, depending on many 
variables such as cell type, cell activation state and microenvironment factors. There are 
several key mechanisms that are involved in regulating the switch between cell survival, 
apoptosis or necroptosis responses. Particularly, the ubiquitin-editing system and the state 
of caspase 8 can modulate the final outcome of this pathway.  
	 Initially, TNFR1 monomers spontaneously assemble forming inactive trimers. When 
the interaction between TNFR1 trimer and TNFα takes place, the receptor changes its 
conformation and it is therefore able to recruit several molecules through its cytosolic 
domain [15]. This recruitment allows the formation of a membrane-proximal supra-
molecular structure known as complex I (Fig. 2A), which contains the TNFR-associated 
death domain (TRADD), the TNFR-associated factor 2 (TRAF2) and 5 (TRAF5), RIPK1, and 
the cellular inhibitor of apoptosis 1 (cIAP1) and 2 (cIAP2) [14].  
	 The assembly of complex I can induce cell survival. cIAP1 and 2 are E3 ubiquitin 
ligases recruited to complex I by TRAF2, which avoids the polyubiquitination and degrada-
tion of cIAP1 and 2, making them more stable in the complex. In this situation, cIAPs can 
trigger polyubiquitination of RIPK1. This post-translational modification provides a platform 
for the interaction between transforming growth factor-β-activated kinase 1 (TAK1), TAK1-
binding protein 2 (TAB2) and 3 (TAB3), but also between IκB kinase α (IKKα), ß (IKKß) and γ 
(IKKγ). Thus, the polyubiquitination of RIPK1 favors the assembly of TAB2-TAB3-TAK1 and 
IKKα-IKKβ-IKKγ complexes that stimulate the canonical nuclear factor-κB (NF-κB) 
activation pathway [16]. This pathway is required for the transactivation of several cytopro-
tective genes and the induction of cell survival. 
	 The activation of NF-κB pathway results in the upregulation of several genes 
including TNFα-induced protein 3 (A20) and FLICE-like inhibitory long isoform protein 
(FlipL). The increased expression of these two proteins is believed to be involved in 
switching TNFR1 activation response to apoptosis [1,14]. A20 is thought to generate a 
negative feedback loop by removing RIPK1-polyubiquitination, which may restrict TNF 
induced NFκB signalling. In addition, cylindromatosis (CYLD), another enzyme with 
deubiquitylating activity, is also implicated in removing polyubiquitin chains from RIPK1. 
When deubiquitinated, RIPK1 can dissociate from complex I and takes part in the formation 
of the cytosolic death inducing signaling complex (DISC) also called complex IIa (Fig. 2B). 
Complex IIa includes TRADD, FADD, FlipL and caspase 8 [14,17]. Its formation is TRADD 
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dependent and is enhanced by the unregulation of FlipL by NFκB pathway. Within the 
complex, FlipL and caspase 8 generate heterodimers that recurit and cleave RIPK1, RIPK3 
and CYLD, inactivating them and preventing necroptosis. Complex IIa also allows the 
formation of procaspase 8 homodimers that are thought to undergo rapid autoproteolysis 
driving caspase 8 activation. Activated caspase 8 dissociates from complex IIa and 
activates caspases 3 and 7 that execute apoptosis. 
	 Alternatively, when cells are depleted of cIAPs, complex I is still formed but RIPK1 is 
not polyubiquitinated [1]. Under these circumstances, complex I induces the activation of 
the non-canonical NF-κB pathway. Furthermore, apoptosis can be triggered by the 
formation of a cytosolic complex named complex IIb or ripoptosome [1,14]. It is a TRADD 
independent complex that includes RIPK1, RIPK3, FADD and the FlipL-caspase 8 
heterodimer. Complex IIb promotes apoptosis in the same manner that complex IIa does it. 
In other occasions, caspase 8 can be inhibited by caspase inhibitors or viral proteins. When 
this happens, apoptosis cannot be carried out and complex IIa and IIb evolve to a different 
cytosolic complex called necrosome [17,18]. 
Executing necroptosis — the necrosome  
Necrosome formation is required for necroptosis execution. The canonical 
necrosome deriving from complex IIa consists of TRADD, RIPK1, RIPK3 and FADD (Fig. 2C), 
while the canonical necrosome resulting from complex IIb lacks TRADD. As a constitutive 
binding partner of RIPK3, MLKL is incorporated in the necrosome [17]. In this situation, 
RIPK1 and RIPK3 are no longer degraded by FlipL-caspase 8 heterodimer and they can 
interact through their respective RIP homotypic interaction motifs (RHIM) [18]. This 
interaction allows the activation and autophosphorylation of RIPK3. The activated RIPK3 
aggregate in fiber-like complexes, probably ß amyloid-like complexes [17]. RIPK3 
aggregates can recruit and activate MLKL, which is the sole and main effector of 
necroptosis pathway identified to date. It has been seen that phosphorylation of human 
RIPK3 at S227 and mouse RIPK3 at S232 is crucial for association with MLKL, but not for 
necrosome assembly [19].  
	 The requirement for RIPK1 can be bypassed by direct activation of RIPK3 by other 
effectors which are RHIM containing proteins that can promote the formation of non-
canonical necrosome forms (Fig. 2D). One of them is the Toll/IL-1 receptor domain-
containing adaptor inducing IFN-b (TRIF) which is recruited by activated TLR3 or TLR4 and 
is able to produce RIPK3 aggregation. Likewise, the DNA-dependent activator of interferon 
regulatory factors (DAI) has been reported to enable RIPK3 aggregation in response to DNA 
viruses infection [18].  
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 3 / Mixed Lineage Kinase domain-Like Protein 
	 MLKL is thought to be the chief effector and the most terminal protein in the 
signalling pathway that leads to necroptosis. Although how MLKL exactly executes 
necroptosis is still a matter of debate, it seems clear that it is through plasma membrane 
integrity disruption. This protein has two functional domains, an N-terminal four-helix 
bundle (4HB) and a C-terminal pseudokinase domain (PsKD), tethered together by a two-
helix linker or brace helices (Fig. 3). The structure of full-length mouse MLKL was solved by 
X-ray crystallography [20]. After that, the human PsKD and N-terminal domain were solved 
separately by X-ray crystallography and Nuclear Magnetic Resonance (NMR) spectroscopy, 
respectively [21,22]. Taken together, the results of these studies provide a good structural 
model of MLKL. 
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Figure 2. Figure 2. Nec optosis is a highly regulated pathway that occurs under caspase-inhibiting conditions. 
(A) Activation of TNFR1 promotes complex I formation, which is the canonical way to trigger 
necroptosis. After that, RIPK1 can be deubiquitinated and released from complex I to generate 
complex IIa or IIa. (B) When complex IIa is assembled and caspase 8 is active, apoptosis is initated. 
However, under caspase-inhibiting conditions complex IIa can lead to the canonical necrosome 
assembly. (C) Within canonical necrosome, RIPK3 is phosphorylated and therefore activated, being 
able to aggregate into fiber-like complexes that recruit MLKL. The interaction between RIPK3 and 
MLKL results in MLKL activation, oligomerisation and membrane translocation. Hence, the canonical 
necrosome formation induces necroptosis. (D) Nonetheless, necroptosis can be triggered through 
non-canonical pathways. The activation of the RHIM containing proteins such as TRIF and DAI can 
induce the formation of non-canonical necrosomes that promote RIPK3 phosphorylation and 
aggregation and the subsequent MLKL activation. 
N-terminal Domain — the killer domain 
The combined domain composed of the 4HB domain and the brace helices is called 
N-terminal domain (NTD). The 4HB domain consists of a four-helices core (H1-H4) which 
interacts with the brace helices but not with the PsKD. In the crystal structure of full-length 
mouse MLKL, electron density was missing for the segments between H3 and H4 and 
between H4 and the first helix of the brace (H1b), evincing the flexibility of these regions [20] 
(Fig. 3A). When the human NTD was solved by NMR spectroscopy an additional core helix 
was present at the site of the missing density between H3 and H4 in mouse full-length 
model [22] (Fig. 3B). This extra helix (H5) is thought to have a dynamic nature responding to 
the protein conformation [23].  
	 The main function of NTD is to execute MLKL necroptotic effect, since expression of 
the MLKL 4HB domain or NTD induces necroptosis in MLKL-/- mouse fibroblasts [24,25]. It is 
generally accepted that plasma membrane is the primary site of MLKL action. This protein 
is known to translocate to plasma membrane after activation—the five core helices of the 
4HB domain are thought to become transmembrane helices while the brace helices are not. 
The core helices are very amphipathic, with hydrophobic surfaces buried inside the domain 
and highly charged surfaces exposed to the solvent in the soluble form. The insertion of the 
4HB domain seems to be driven by specific side-chain interactions between positive 
residues in the domain and negatively charged phospholipids, basically phosphoinositides 
(PIPs) (Fig. 4A). The 4HB domain-PIPs engagement is considered to happen in a two-step 
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Figure 3. MLKL has two functional domains, the N-terminal 4HB domain and the C-terminal PsKD. 
They are joined together by two brace helices. (A) In the full-length mouse model the 4HB domain, 
PsKD and brace helices are represented in green, pink and grey respectively. (B) In the full-length 
reconstructed human model the 4HB domain, PsKD and brace helices are represented in blue, 
orange and grey respectively. Of note, the human 4HM domain presents an extra helix (H5). 
mode: a first low-affinity recruitment followed by a second robust membrane association 
that leads to insertion (Fig. 5) [26]. 
	 The charged surfaces exposed in the soluble form cannot be inserted into the 
phospholipid bilayer. Nonetheless, there is a poorly packed interface between helices H2 
and H4 that acts as a natural gate where the structure can open to expose the hydrophobic 
faces of the helices facilitating the insertion into the bilayer [22]. Related to that, it has been 
proposed a plug release mechanism by which H1b operates as an inhibitor of the 4HB 
domain insertion. H2 and H4 are packed against the N-terminal portion of H1b in human 
and mouse structural models of the soluble MLKL. Notably, some residues of H2 and H1b 
are close enough to suggest a dynamic interaction between these two segments [23] (Fig. 
4B). The binding of H1b to the groove between helices H2 and H4 is expected to stabilize 
the soluble form of MLKL, hindering the opening of the 4HB domain and preventing the 
interaction with PIPs. The conformation changes in activated MLKL and its interaction with 
PIPs are the main forces that are thought to promote the H1b displacement and disordering, 
permitting membrane insertion (Fig. 5). 
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Figure 4. The solved structures of MLKL suggest that PIP binding site may involve clusters of 
positively charged K and R residues. (A) These basic residues are represented as sticks divided in 
two main PIP binding clusters, one comprising basic residues in H1 (blue) and H2 (green) and the 
other one comprising basic residues preceding H3 (pink) and some residues in H5 (orange). There 
are some residues that are thought to be involved in PIP binding in H4 (light brown). (B) The basic 
residues in H2 play a double role as they are involved in PIP binding but they also interact with 
acidic residues on the brace, which are represented as sticks. The brace displacement is required 
to obtain a total 4HB domain-membrane interaction because it releases H2 basic residues. 
However, this displacement is driven by the interaction between H2 and PIPs. 
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	 Once translocated to the plasma membrane, MLKL generates cation fluxes 
increasing osmotic pressure, eventually causing membrane rupture. There is an ongoing 
debate on the precise mechanism by which it happens. The 4HB domain does not share 
significant sequence or structural homology to other protein families. This complicates the 
structural/functional study of MLKL, as it is not possible to infer how the 4HB domain 
permeabilises membranes studying homologous proteins [23]. Current models for MLKL 
membrane permeabilisation mechanism includes multi-step, partial insertion of 4HB 
domain to disrupt membranes (Fig. 6A) [24], insertion of 4HB to interact with ion channels 
including transient receptor potential melastatin-like 7 (TRPM7) to mediate osmolysis (Fig. 
6B) [25], total insertion of NTD to form an ion channel itself (Fig. 6C) [26] or whole 
embedment of MLKL oligomers to form disrupting pores (Fig. 6D) [28]. Of note, none of 
these mechanisms exclude oligomerisation. 
MLKL role in necroptosis — a structral overview / 12
A Partial insertion B Association with  auxiliary transporters
C Selective cation  
channel
D Oligomerisation and release  
of cellular contents
Figure 6. 
Figure 6. The mechanism by which MLKL provokes membrane integrity loss is still unknown. 
Different reports adduce different plausible modes which include: (A) MLKL partial insertion, (B) 
MLKL association and activation of auxiliary transporters, (C) MLKL insertion to act as a selective 
cation channel and (D) oligomer-pores formation. None of these mechanisms exclude 
oligomerisation.
Figure 5. MLKL interaction with the membrane is thought to happen in a two-step way. (A) Firstly, 
H1 basic residues interact with the membrane PIPs. (B) This first step promotes H2-PIP 
engagement and brace disordering, which is the second step of the process. (C) When this happens 
H2-H4 interaction is disrupted and 4HB domain can open and insert into the bilayer. 
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	 Recent studies suggest that MLKL works as an oligomer. Although MLKL oligormes 
have been reported at the plasma membrane of necroptotic cells in several studies, the 
stoichiometry of oligomerisation remains unknown: trimers [24], tetramers [25] and even 
hexamers [28] or octamers [29] have been described. The interface through which MLKL 
self-associates is also unknown but the brace helices appear to be involved in the 
oligomerisation process [22,26]. Considering that 4HB domain alone is able to induce 
necroptosis without oligomerising, it is possible that brace mediated-oligomerisation 
serves to stabilize the active conformation of MLKL rather than govern MLKL killing activity 
[23]. 
C-terminal Pseudokinase Domain — the regulator domain 
PsKD is the C-terminal domain of MLKL and it topologically resembles protein 
kinase domains. However, it lacks critical residues that are necessary for phosphoryl-
transfer, becoming catalytically-defective [20, 30]. Conventional kinase domains are bilobal, 
they present the N-terminal lobe (N-lobe) that packs against the larger C-terminal lobe (C-
lobe). The N-lobe contains five antiparallel β-strands (ß1-ß5) and one α-helix (αC helix) 
while the C-lobe is almost entirely composed of α-helices [31] (Fig. 3). Kinase domains have 
a strictly organized internal architecture which is also very dynamic and allows regulation 
events. The main functional features of kinase domains rely on highly conserved sequence 
and structural motifs shared by most active kinases [31]. In fact, all conventional protein 
kinases have at least three essential conserved motifs: the VAIK motif, the DFG motif and 
the HRD motif. All of them play a paramount role in kinase catalytic activity (for a complete 
revision on kinase motifs see ref. [31]). The PsKD conserves the bilobal structure and the 
secondary structure of protein kinases. Despite that, most MLKL’s PsKD from different 
species have modifications in the mentioned motifs. Whereas VAIK motif seems to be 
conserved, HRD motif is replaced by divergent sequences and DFG motif has been modified 
in most orthologs to GFE [32].  
	 Over the last years, pseudokinase domains have been demonstrated to have relevant 
functions as signalling pathway regulators. An emerging idea is that pseudokinases might 
act as molecular switches, being able to modulate signalling pathways accordingly to 
upstream signals. Related to that, the PsKD is thought to function as a molecular switch 
that permits the structural rearrangement between the active and inactive conformations of 
MLKL. The upstream signal in this case is the phosphorylation of PsKD. Both human and 
mouse PsKD have been shown to be phosphorylated by RIPK3 at S/T residues, which are 
T357 and S358 in human and S345, S347, T349 and S352 in mouse [30]. The interaction of 
MLKL and RIPK3 takes place between the N-lobe of PsKD and the N-lobe of RIPK3—as it is 
13 / MLKL role in necroptosis — a structral overview 
a kinase, it has N and C-lobes. The domains pack against each other through an interface 
dominated by Van der Waals interactions, H-bonds and π-stacking phenylalanine rings from 
RIPK3 and MLKL [30]. MLKL phosphorylation is known to correlate with its oligomerisation 
and membrane translocation. Hence, phosphorylation of PsKD is essential to MLKL 
activation. In addition, it is secondary to RIPK3 engagement since the alanine mutation of 
the phosphorylation-site residues does not preclude MLKL binding to RIPK3 [23]. 
	 These RIPK3-mediated phosphorylations are thought to induce conformational 
changes within the activation loop of the PsKD. The activation loop is a flexible regulatory 
element present in kinase proteins that allows kinase activation when phosphorylated. This 
loop is usually packed against the αC helix, which in turn interacts with the VAIK motif — the 
conserved E in αC helix ion pairs with the catalytic K of the VAIK motif [31]. Curiously, in 
PsKD this last interaction has been lost and it has been replaced by a new one. In the 
structure of full-length mouse MLKL K219 of the VAIK motif interacts with Q343 in the 
activation loop helix, a residue largely conserved amongst MLKL orthologs, while E239 of 
the αC helix faces the solvent (Fig. 7) [20].  
	 The functional importance of the K219:Q343 interaction was corroborated by alanine 
mutation of either residue. The mutations induced necroptosis in absence of stimuli [20], 
indicating that the K219:Q343 interaction is important to mantain MLKL in an inactive state. 
Furthermore, these interacting residues are proximal to the RIPK3-mediated phospho-
rylation-sites. Taken together, these findings suggest that the phosphorylation of PsKD in 
the activation loop is a key step for MLKL activation via K219:Q343 interaction disruption, 
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Figure 7. 
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Figure 7. PsKD is believed to act as a switch mechanism that regulates the activation of MLKL and 
the release of 4HB domain. One of the most relevant structural features that support this 
hypothesis is the K219:Q343 interaction. The figure shows the αC helix (green), the activation loop 
helix (orange) and the VAIK motif (blue). Some of the phosphorylation sites are displayed (yellow) 
to demonstrate its proximity to the regulating interaction. Important residues are represented as 
sticks. The structure corresponds to mouse PsKD. Of note, the activation loop of mouse MLKL 
adopts an α-helix structure rather unusual [20].
supporting the molecular switch hypothesis. It is believed that these conformational 
changes are transmitted by the brace helices to the 4HB domain. Thus, the PsKD structural 
rearrangement is coupled to the 4HB domain release and MLKL total activation.  
4 / Conclusions 
Over the years, our understanding of cell death signalling has increased 
substantially. It is now clear that necrosis can take place in a programed manner via 
multiple molecular pathways such as necroptosis. Necroptosis is a regulated type of cell 
death that combines apoptotic and necrotic features and integrates many stimuli. The key 
necroptosis effector is MLKL. Simplistically, MLKL activation is triggered by RIPK3-
mediated phosphorylation of the PsKD which induces a change in K219:Q343 interaction 
that is coupled with a structural rearrangement of the brace helices. This structural 
reorganization will cause the release of the 4HB domain that will induce the oligomerisation 
and the membrane translocation of MLKL, eventually provoking necroptosis execution (Fig. 
8). Still, one has to take into account many other variables that can modulate MLKL 
activation. For instance, apart from the mentioned phosphorylations, MLKL has additional 
phosphorylation and ubiquitination sites and some of them can negatively regulate its 
activity [23]. Besides, MLKL has been recently identified as a client of Hsp90 and the protein 
kinase co-chaperone CDC37 [33] suggesting an extra regulating point. Indeed, Hsp90 is 
believed to ease the oligomerisation, the membrane translocation and the transmission of 
the phosphorylation-induced conformational changes from PsKD to 4HB domain.  
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Figure 8. It is still difficult to asses how MLKL is activated and which are the steps that follow 
its activation. This figure presents a simple model that describes these events and seems to 
fit in with the current data.
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MLKL has two functional domains:  
N-terminal four-helix bundle (4HB) 
C-terminal pseudokinase domain (PsKD) 
Tethered together by a two-helix  
linker (brace helices, H1b and H2b) 
N-Terminal Domain (NTD) refers to  
4HB and brace helices grouped
Necroptosis is a regulated type of necrosis that occurs in cells in 
which the execution of apoptosis is inhibited. It can be triggered by 
pro-apoptotic stimuli, but develops in a caspase-independent 
manner and shows morphological characteristics resembling 
necrosis. Necrosome formation is required for necroptosis execution. 
The canonical necrosome consists of a specific set of molecules — 
receptor-interacting protein 1 (RIPK1) and 3 (RIPK3) and MLKL are 
the most relevant ones. Whitin the necrosome, the activated RIPK3 
aggregate in fiber-like complexes which can recruit MLKL and 
activate it by phosphorylation. 
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C-terminal Pseudokinase Domain — the Regulator Domain
PsKD topologically resembles protein kinase domains but it is catalytically-defective. This domain 
functions as a molecular switch that allows the transition from inactive to active conformations of MLKL.
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channel
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Figure 6. 
N-terminal Domain — the Killer Domain 
MLKL provokes necroptosis through plasma membrane integrity disruption. NTD is the effector of MLKL 
necroptotic effect, in particular the 4HB which is thought to become transmembrane during necroptosis. The 
4HB helices are very amphipathic, with hydrophobic surfaces buried inside the domain and highly charged 
surfaces exposed.
When translocated into the bilayer, MLKL generates an increased osmotic pressure that cause membrane 
rupture. There are several models for MLKL membrane permeabilisation mechanism. 
Membrane insertion
Membrane Disruption
1. Initial Engagement. Interactions between positive residues of 4HB and negatively charged phospho-
inositides (PIPs) in the membrane drive MLKL-membrane engagement. 
2. 4HB Domain Insertion — Plug Release Mechanism. There is a poorly packed interface between 
helices H2 and H4 that acts as a natural gate where the structure can open to expose the hydrophobic 
residues, facilitating the insertion into the bilayer.
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Activation model. MLKL activation is triggered by RIPK3-mediated phosphorylation of the PsKD that disrupts 
K219:Q343 interaction and it is coupled with brace helices structural rearrangement. This reorganization cause 
oligomerisation and the release of the 4HB domain. 4HB bec mes transmembrane and eventually cause necroptosis 
execution.
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Methodology
To report the historical knowledge in cell death processes. 
To differentiate the terms necroptosis and regulated necrosis. 
To depict the molecular basis of necroptosis
To characterise the structural features of MLKL
To describe the functional role of MLKL in necroptosis
To generate mature conclusions 
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Final Project
For a long time apoptosis was considered the standard programmed 
cell death process, whereas necrosis was mostly assumed as an 
accidental cell death mode related to pathological circumstances. 
Nowadays it is clear that necrosis can occur in a finely regulated 
manner during physiological and pathological processes. There are 
multiple modes of regulated necrotic cell, each one with distinct 
underlaying signalling pathways. The current work will focus on 
necroptosis pathway and its key effector:
the Mixed Lineage Kinase  
Domain-like Protein (MLKL).
1. Murphy JM, Czabotar PE, Hildebrand JM, Lucet IS, Zhang J-G, Alvarez-Diaz S, et al. The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism. Immunity. 2013;39(3):443–53. 
2. Su L, Quade B, Wang H, Sun L, Wang X, Rizo J. A plug release mechanism for membrane permeation by MLKL. Structure 2014; 22(10): 1489-500. 
3. Petrie EJ, Hildebrand JM, Murphy JM. Insane in the membrane: A structural perspective of MLKL function in necroptosis. Immunol Cell Biol. 2017;95(2):152–9.
	 Currently, we are on a start position for a more detailed examination of MLKL 
mechanism of action at the membrane. Obtaining knowledge about the MLKL and other 
molecules can help us to better understand the sequential interactions and events that 
ultimately lead to nectoptosis execution. To this purpose, the structural and biophysical 
technics can give us really valuable information. The use of high resolution structural 
techniques as cryo-electron microscopy in combination with biochemical and cellular 
assays will be crucial in resolving the debate about the precise mechanism of MLKL action 
and enlarging the current knowledge in necroptosis.  
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Figure references 
Figure 1. Took from reference [11].  
Figure 2.  Self-created based on references [1,18] 
Figure 3. Self-created using UCSF Chimera. The structures were found in PDB and the codes are 
4BTF, 4M67 and 2MSV for mouse full-length MLKL structure, human PsKD structure and human NTD 
structure, respectively. The human full-length model was build by overlapping the human partial 
structures to the mouse full-length structure.  
Figure 4. Self-created using UCSF Chimera and Pymol. The structure was found in PDB and its code 
is 2MVS. Based on reference [26]. 
Figure 5. Self-created based on reference [26].  
Figure 6. Self-created based on reference [23]. 
Figure 7. Self-created using UCSF Chimera. The structure was found in PDB and its code is 4BTF. 
Based on reference [32]. 
Figure 8. Self-created.  
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